Sign In
Buy AMRX
$12.88
+0.225 (+1.78%)
At Close: Jun 03, 2026
Amneal to Acquire Substantially All of Kashiv Specialty Pharmaceuticals
06:00am, Tuesday, 12'th Jan 2021
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (the “Company”) (NYSE:AMRX) and Kashiv BioSciences LLC (“Kashiv”) today announced they have entered into a definitive agreement
Amneal to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
09:23am, Tuesday, 05'th Jan 2021
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that Chirag Patel, Amneal's Co-Chief Executive Officer and President, will present at
Amneal Analyst: Pharma Well-Positioned Ahead Of 2021 Generic Launches
02:45pm, Monday, 14'th Dec 2020
As part of its outlook for biopharma companies in 2021, Guggenheim Securities turned bullish on Amneal Pharmaceuticals Inc (NYSE: AMRX). The Amneal Analyst: Dana Flanders upgraded Amneal from Neutral
Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5%
08:35am, Wednesday, 11'th Nov 2020
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) today announced that it has received approval for its Abbreviated New Drug Application (ANDA) from the U.S.
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2020 Results - Earnings Call Transcript
05:28pm, Friday, 06'th Nov 2020
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2020 Results - Earnings Call Transcript
Recap: Amneal Pharmaceuticals Q3 Earnings
07:53am, Friday, 06'th Nov 2020
Shares of Amneal Pharmaceuticals (NYSE:AMRX) rose 1.0% in pre-market trading after the company reported Q3 results.
Amneal Reports Third Quarter 2020 Financial Results
06:00am, Friday, 06'th Nov 2020
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the third quarter ended September 30, 2020. “Amneal delivered anothe
The Global Epinephrine Autoinjector Market will grow by USD 762.51 mn during 2020-2024
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates
12:35pm, Thursday, 06'th Aug 2020
Amneal (AMRX) delivered earnings and revenue surprises of 30.00% and 3.73%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Amneal Reports Second Quarter 2020 Financial Results
10:00am, Thursday, 06'th Aug 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the second quarter ended June 30, 2020.
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Amneal (AMRX) to Report Q2 Earnings: What's in the Cards?
04:08pm, Monday, 03'rd Aug 2020
Amneal (AMRX) will provide financial updates when it reports second-quarter 2020 results.
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Amneal Pharmaceuticals (AMRX) Stock Sinks As Market Gains: What You Should Know
09:45pm, Friday, 31'st Jul 2020
Amneal Pharmaceuticals (AMRX) closed the most recent trading day at $4.33, moving -0.69% from the previous trading session.
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
04:33pm, Thursday, 30'th Jul 2020
Amneal (AMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
